147 related articles for article (PubMed ID: 15066468)
1. Childhood tumor risk after treatment with ovulation-stimulating drugs.
Brinton LA; Krüger Kjaer S; Thomsen BL; Sharif HF; Graubard BI; Olsen JH; Bock JE
Fertil Steril; 2004 Apr; 81(4):1083-91. PubMed ID: 15066468
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk associated with ovulation-stimulating drugs.
Brinton LA; Scoccia B; Moghissi KS; Westhoff CL; Althuis MD; Mabie JE; Lamb EJ
Hum Reprod; 2004 Sep; 19(9):2005-13. PubMed ID: 15217997
[TBL] [Abstract][Full Text] [Related]
4. Association between fertility drugs and gynecologic cancers, breast cancer, and childhood cancers.
Ayhan A; Salman MC; Celik H; Dursun P; Ozyuncu O; Gultekin M
Acta Obstet Gynecol Scand; 2004 Dec; 83(12):1104-11. PubMed ID: 15548140
[TBL] [Abstract][Full Text] [Related]
5. Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Cancer Causes Control; 2008 Sep; 19(7):759-65. PubMed ID: 18340541
[TBL] [Abstract][Full Text] [Related]
6. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
[TBL] [Abstract][Full Text] [Related]
8. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
[TBL] [Abstract][Full Text] [Related]
9. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
[TBL] [Abstract][Full Text] [Related]
10. Uterine cancer after use of clomiphene citrate to induce ovulation.
Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
[TBL] [Abstract][Full Text] [Related]
11. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
Jensen A; Sharif H; Kjaer SK
Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer risk associated with varying causes of infertility.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Fertil Steril; 2004 Aug; 82(2):405-14. PubMed ID: 15302291
[TBL] [Abstract][Full Text] [Related]
13. In vitro fertilization and breast cancer risk: a review.
Salhab M; Al Sarakbi W; Mokbel K
Int J Fertil Womens Med; 2005; 50(6):259-66. PubMed ID: 16526416
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
15. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
16. The possible association between IVF and breast cancer incidence.
Pappo I; Lerner-Geva L; Halevy A; Olmer L; Friedler S; Raziel A; Schachter M; Ron-El R
Ann Surg Oncol; 2008 Apr; 15(4):1048-55. PubMed ID: 18214616
[TBL] [Abstract][Full Text] [Related]
17. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
[TBL] [Abstract][Full Text] [Related]
18. Risk of multiple gestation after ovulation induction in polycystic ovary syndrome.
Ratts VS; Pauls RN; Pinto AB; Kraja A; Williams DB; Odem RR
J Reprod Med; 2007 Oct; 52(10):896-900. PubMed ID: 17977162
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with polycystic ovary syndrome.
Neveu N; Granger L; St-Michel P; Lavoie HB
Fertil Steril; 2007 Jan; 87(1):113-20. PubMed ID: 17081535
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer and fertility medications: a critical appraisal.
Kashyap S; Davis OK
Semin Reprod Med; 2003 Feb; 21(1):65-71. PubMed ID: 12806561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
